Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Macular Edema

• A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
• Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
• Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
• Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)
• A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular
• Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
• A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macu
• Cool vs Room-temperature Artificial Tears
• Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
• Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
• Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
• A Phase 2 Evaluation of Tonabersat for DME
• Comparison of Treatments in Diabetic Macular Edema
• Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
• Safety and Effect of Intravitreal Delivery of Zidovudine Derivative, K8, in Subjects With Diabetic Macular Edema
• Effect of AIV007 by Periocular Administration in Subjects With nAMD or DME
• Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
• RO7200220 in Participants With Uveitic Macular Edema
• A Study to Investigate RO7200220 in Participants With Uveitic Macular Edema
• Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
• Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
• Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
• Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
• Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema
• The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)
• Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema
• A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema
• Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)
• Effect of Corona Virus on Intravitreal Injections
• Minocycline Treatment for Cystoid Macular Edema
• Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (AMD) or Subjects With Diabetic Macular Edema (DME).
• Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
• Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions
• Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
• Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
• Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema
• Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
• AG-73305 Single Ascending Dose Cohort Study in DME
• Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions
• Changes After Suprachoroidal Injection.
• Ranibizumab Versus Aflibercept for CRVO in Young Patients.
• Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
• Effectiveness of Periocular Drug Injection in CATaract Surgery
• A Study to Investigate RO7200220 in Combination With Ranibizumab in Diabetic Macular Edema
• A Study to Investigate RO7200220 in Diabetic Macular Edema
• Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
• EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
• An Innovative Chinese Herbal Formula for Macular Edema
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants
• Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema
• DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
• Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema
• A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
• The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion
• Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
• A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina
• BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema
• PCME Prevention in Patients With NPDR
• Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema
• Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (DME)
• Ozurdex in Suboptimal Diabetic Macular Edema Patients
• Non-Responsive Diabetic Macular Edema and Spironolactone
• Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
• First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers
• Clinical Study of the Safety and Efficacy of BAT5906 Injection
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
• Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
• Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
• Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema and CRVO
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients
• Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
• Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
• Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
• A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
• A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
• Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
• RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
• A Study to Evaluate the Safety and Tolerability of EXN407
• Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
• The PRIME Study: A Randomized, Controlled, Prospective Study
• Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
• Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment o
• A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
• Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
• Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema
• Combination of Ranibizumab and Targeted Laser Photocoagulation
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
• Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
• Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
• DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
• Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF
• Study 212669: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
• Use of Ziv Aflibercept in Different Retinal Diseases
• Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan
• Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
• MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
• The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
• Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab
• Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)
• This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab
• Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema
• Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)
• A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion
• Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
• Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
• Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
• To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
• Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
• Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema
• A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
• Anti-VEGF Therapy Versus Dexamethasone Implant for DME
• The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)
• One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab
• Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab
• A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
• Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
• Cataract DME - Peri vs. Intraop
• Post Intravitreal Injection Topical NSAID vs. Patching
• Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
• Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
• Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema
• A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
• Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
• The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
• Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
• Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME
• A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
• Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema
• Navigated Laser In Branch Retinal Vein Occlusion Study
• The Study to YD312 Tablet in Patients With Diabetic Macular Edema
• Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
• Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema
• Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial
• Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
• Prophylactic Effect of Ketorolac Tromethamine on the Cystoid Macular Edema After Phacoemulsification in Diabetic Patients
• A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
• A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)
• To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus
• A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• The Effects of Intravitreal Ozurdex Implant in DME
• Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)
• Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
• Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
• Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion
• Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept
• Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients
• Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema
• Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME
• Study for Optimizing Anti-inflammatory Prophylaxis
• Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3
• Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
• PROMINENT-Eye Ancillary Study (Protocol AD)
• IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
• RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery.
• Ranibizumab Plus Indomethacin
• Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA
• Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion
• Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
• Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
• Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
• Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
• Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)
• Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
• Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
• Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
• Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
• Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
• Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema
• Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema
• Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
• Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
• Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
• Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema
• Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema
• Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
• Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study
• 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
• A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
• Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema
• Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy
• Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
• Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
• The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema
• Pain and Visual Outcome in Intravitreal Bevacizumab Injection
• Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
• 3 Month Outcome of Ziv-aflibercept for DME
• Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
• Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema
• Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
• Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
• The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema
• Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
• Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
• Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
• Aflibercept in Recurrent or Persistent CNV
• Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
• Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema
• Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
• Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
• Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients
• Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
• The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema
• Mean Visual Acuity Changes Following Five Injections of Aflibercept
• Anti-VEGF Treatment for Prevention of PDR/DME
• Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
• Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
• Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
• Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
• Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
• Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
• Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
• Intravitreal Injections of Ziv-aflibercept for Macular Diseases
• Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
• To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.
• Study of DS-7080a for the Treatment of Macular Degeneration
• Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas
• Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
• Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
• Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema
• Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion
• A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Co
• Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema
• To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
• Photobiomodulation for the Treatment of Diabetic Macular Edema
• The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates
• Topical Nepafenac as Supplement for Diabetic Macular Edema
• Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
• Special Drug Use Investigation of EYLEA for Diabetic Macular Edema
• Phase 4 IOP Signals Associated With ILUVIEN®
• Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
• Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema
• Variable Interval Versus Set Interval Aflibercept for DME
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
• The Endurance 1 Trial
• Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME
• A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients
• Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
• Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
• Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
• Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients
• Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
• A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
• Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema
• Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
• Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
• The Endurance 1 Trial
• Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
• Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME
• A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients
• Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
• Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
• Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema
• Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
• Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
• Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
• A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME
• An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
• A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
• Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
• Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.
• Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa
• Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
• A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
• Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
• Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
• Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab
• A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
• Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
• Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
• Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
• Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
• Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
• The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
• Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
• Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
• Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
• Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
• Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
• Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
• Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
• Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
• Ranibizumab Treatment for Retinal Vein Occlusion
• Diabetic Macular Edema Treated With Ozurdex (DMEO)
• Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
• Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome
• Phase II Combination Steroid and Anti-VEGF for Persistent DME
• Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
• A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
• Treatment for CI-DME in Eyes With Very Good VA Study
• An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
• Nepafenac Once Daily for Macular Edema - Study 2
• TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
• NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
• Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
• Nepafenac Once Daily for Macular Edema - Study 1
• To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
• Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab
• Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
• Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment
• Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
• AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
• A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
• Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
• Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
• Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• PRevention of Macular EDema After Cataract Surgery
• Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
• Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)
• Dexamethasone-implant for the Treatment of RVO
• The Effect of Intravitreal Ozurdex on DME After Cataract Surgery
• Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
• A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes
• Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
• Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
• Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
• A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
• Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye
• Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)
• Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival
• Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)
• Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
• Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
• Ranibizumab and Bevacizumab for Diabetic Macular Edema
• Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
• Intravitreal Aflibercept Injection for Radiation Retinopathy
• Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
• Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion
• A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Ed
• The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
• Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)
• Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
• Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery
• A Long-Term Safety Study of OZURDEX® in Clinical Practice
• Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
• Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema
• Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
• A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
• Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
• Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
• A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
• Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
• Safety Study of ALG- 1001 to Treat Diabetic Macular Edema
• Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
• Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
• Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
• Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
• PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)
• Dextromethorphan for Diabetic Macular Edema
• Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
• Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
• Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
• Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
• Topical Interferon Gamma for Macular Edema Secondary to Uveitis
• Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
• Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
• Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
• A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema
• Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
• Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
• Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
• Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Ranibizumab "Treat and Extend" in Diabetic Macular Edma
• Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
• Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
• Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
• A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
• Ozurdex for Macular Edema Post Membrane Peeling
• Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
• Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
• REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
• Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
• Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
• Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema
• Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion
• Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema
• Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
• Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
• Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
• Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema
• Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema
• Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
• A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
• MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)
• A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
• Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
• Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion
• Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
• Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)
• Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
• Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
• Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
• Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema
• Prophylactic Ketorolac Post Epiretinal Membrane Surgery
• Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion
• Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
• Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
• Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
• The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
• Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)
• Macular Edema Incidence/Severity Reduction With Nevanac
• SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
• Efficacy Study of Methotrexate to Treat Sarcoid-associated Uveitis
• Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
• Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema
• Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
• The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
• Supplemental Adjuvants for Intracellular Nutrition and Treatment
• Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
• Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)
• Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
• Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
• Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
• Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion
• Combined Triple Therapy in Diabetic Retinopathy (DRP)
• Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab
• Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation
• Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation
• Avastin for Post-Photocoagulation Macular Edema
• Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery
• Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
• Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
• DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact
• A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
• Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema
• Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
• Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
• Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema
• Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema
• Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.
• Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema
• Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
• Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)
• Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
• Sirolimus to Treat Diabetic Macular Edema
• Intravitreal Bevacizumab for Diabetic Macular Edema
• Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema
• Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
• A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)
• A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
• Effect of Choline Fenofibrate (SLV348) on Macular Edema
• Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
• Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
• Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser
• Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
• A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
• Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study
• Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
• Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema
• A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
• POSTERIOR SUB-TENON'S Avastin
• Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
• Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
• Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
• Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
• Treatment of Refractory Diabetic Macular Edema With Infliximab
• Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema
• Lucentis for Inflammatory Macular Edema Trial
• Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
• Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
• Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
• Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
• Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
• Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
• Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
• A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
• Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
• Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema
• Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
• Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
• Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema
• Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
• A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
• Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
• The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
• Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
• Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
• Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
• Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema
• Intravitreal Bevacizumab for Retinal Disorders
• Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
• An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
• Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
• To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
• Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
• Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
• A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
• A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
• The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
• Bevacizumab and Retinal Vascular Occlusions
• Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
• Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
• Effect of Prophylactic Ketorolac on CME After Cataract Surgery
• Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)
• Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
• Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
• A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
• Efalizumab to Treat Uveitis
• Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
• Triamcinolone vs. Laser for Diabetic Macular Edema
• PST/Laser v. Laser Alone for CSME
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
• A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
• A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
• Effect of Ruboxistaurin on Clinically Significant Macular Edema
• Study to Treat Uveitis Associated Macular Edema
• Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage
• Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
• The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders
• Reduction in the Occurrence of Center-Involved Diabetic Macular Edema
• Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
• Laser and Antioxidant Treatment of Diabetic Macular Edema
• Laser and Medical Treatment of Diabetic Macular Edema
• Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
• Research Study in Patients With Persistent Macular Edema
• Laser and Medical Treatment of Diabetic Macular Edema
• Vitamin E to Treat Uveitis-Associated Macular Edema
• Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema